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Abstract 
 
Background: Adolescent depression prevention research has focused on mean intervention 
outcomes, but has not considered heterogeneity in symptom course. Here, we empirically identify 
subgroups with distinct trajectories of depressive symptom change among adolescents enrolled in two 
indicated depression prevention trials and examine how cognitive-behavioral (CB) interventions and 
baseline predictors relate to trajectory membership.  
Methods: 631 participants were assigned to one of three conditions: CB group intervention, CB 
bibliotherapy, and brochure control. We used group-based trajectory modeling to identify trajectories of 
depressive symptoms from pretest to 2-year follow-up. We examined associations between class 
membership and conditions using chi-square tests and baseline predictors using multinomial regressions.  
Results: We identified four trajectories in the full sample. Qualitatively similar trajectories were 
found in each condition separately. Two trajectories of positive symptom course (Low-Declining, High-
Declining) had declining symptoms and were distinguished by baseline symptom severity. Two 
trajectories of negative course (High-Persistent, Resurging) respectively showed no decline in symptoms 
or decline followed by symptom reappearance. Participants in the brochure control condition were 
significantly more likely to populate the High-Persistent trajectory relative to either CB condition and 
were significantly less likely to populate the Low-Declining trajectory relative to CB group. Several 
baseline factors predicted trajectory classes, but gender was the most informative prognostic factor, with 
males having increased odds of membership in a High-Persistent trajectory relative to other trajectories. 
Conclusions: Findings suggest that CB preventive interventions do not alter the nature of 
trajectories, but reduce the risk that adolescents follow a trajectory of chronically elevated symptoms. 
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Introduction 
 
Adolescent depression is a prevalent and disabling condition that increases the risk of academic 
and occupational failure, interpersonal problems, comorbid psychopathology, and suicidality.[1-4] 
Considerable research has been devoted to developing effective interventions to prevent this disorder, 
with cognitive behavioral (CB) programs receiving most support.[5-7] To date, prevention programs have 
been examined using variable-centered (nomothetic) methods, which assume homogeneous change in 
intervention and control conditions. For this reason, little is known regarding the nature of heterogeneity 
in the symptom course of participants in prevention randomized controlled trials (RCTs). An approach to 
examine this heterogeneity is to use person-centered (idiographic) methods, such as group-based 
trajectory modeling.[8; 9] This approach has been used to identify subgroups with qualitatively distinct 
symptom trajectories in natural development (e.g.,[10-13]) and in response to treatment in adults.[14-18] 
In general populations of adolescents, trajectory modeling has demonstrated that the development of 
depressive symptoms is characterized by multiple trajectories, with four replicated in several studies 
(chronically low, chronically high, increasing, decreasing) (e.g.,[10-13]). However, to our knowledge, this 
approach has never been used in depression prevention RCTs.  
Group-based trajectory modeling may be useful for several reasons in prevention research. First, 
the method allows one to empirically identify typical symptom trajectories observed in RCTs in terms of 
number, shape and prevalence[9] and may thus provide a valuable description of patterns of response and 
non-response to interventions. Empirical trajectory classifications may be less arbitrary than common 
indicators used to define intervention response and non-response.[17] Second, trajectory modeling may 
offer a comprehensive understanding of intervention effects. The approach may reveal whether 
interventions move participants from problematic to healthy trajectories and clarify the nature and timing 
of effects for different subgroups. Third, trajectory modeling may be useful to investigate predictors of 
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differential response to interventions.[15-18] Predicting who does and does not benefit from interventions 
is essential to reducing the risk of adverse effects in some participants, to refining interventions, and to 
determining which intervention should be offered to which participants.[19] Studies have examined 
moderators of intervention effects (e.g.,[20-24]) but few findings have replicated.[5; 7] Trajectory 
modeling may reveal factors associated with multiple patterns based on the course of symptoms over time 
(e.g., two or more qualitatively distinct trajectories of poor response)[15] which may be overlooked by 
general moderation analyses focusing on specific time points, 
In this study, we used group-based trajectory modeling to re-examine data from two large 
adolescent depression prevention RCTs. The trials respectively tested the efficacy and effectiveness of a 
brief indicated CB group intervention (the Blues Program) in relation to two alternative conditions: CB 
bibliotherapy and brochure control.[25; 26] Previous variable-centered analyses showed that the CB 
group intervention reduced mean depressive symptoms and the incidence of depression onset over follow-
up relative to brochure control.[25; 26] The first objective of the present investigation was to identify 
subgroups with distinct trajectories of depressive symptoms from pretest to 2-year follow-up in a 
combined sample from the two RCTs. Our second objective was to determine how conditions related to 
the trajectories and, in particular, whether CB interventions were associated with increased membership 
in trajectories with positive symptom course relative to brochure control. Our third objective was to 
identify baseline predictors associated with trajectory membership, with a focus on identifying factors that 
could distinguish positive and negative symptom courses prior to intervention. We considered six factors 
(sex, age, negative cognitive style, substance use, motivation to reduce depression, intervention 
expectancy) that have shown theoretical or empirical relevance in previous moderator research on 
adolescent depression prevention or intervention outcomes more generally.[5; 7; 20; 21; 27; 28] In 
contrast to most previous studies that used group-based trajectory modeling in clinical research, we 
analyzed both intervention and control conditions together whenever possible, as this is necessary to 
make inferences regarding intervention effects.
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Method 
 
Participants 
 
The sample included 631 participants from the efficacy (n=253) and effectiveness (n=378) RCTs 
of the Blues Program.[25; 26] Participants were randomly assigned to one of three conditions: brief CB 
group Blues Program (n=215), CB bibliotherapy (n=208), and brochure control (n=208). An additional 
condition was included only in the efficacy trial (supportive-expressive intervention) and was excluded 
here. The sample included a majority of females (58%) and age ranged from 13 to 19 (M=15.5, SD=1.2). 
The sample included a majority of Caucasian adolescents (61%), and a minority of Asians (2%), African 
Americans (5%), Hispanics (17%), Native Americans (1%), and adolescents of mixed heritage (15%). 
Most participants had at least one parent with a college degree or higher (51%). Participants were 
recruited via mass mailings, handbills, and posters. Interested participants completed two versions of the 
Center for Epidemiologic Studies – Depression (CES-D)[29] questionnaire as a screener. Scores of 20 or 
higher were used for inclusion in the efficacy trial, and endorsement of two symptoms or more on a 
modified CES-D (which was not collected) was used for inclusion in the effectiveness trial. Exclusion 
criteria were current MDD and acute suicidal ideation (effectiveness trial specifically). Detailed 
procedures are described elsewhere.[25; 26] 
 
CB group depression prevention intervention (blues program) 
 
The CB group program included six weekly 1-hr sessions. Each session had two components:  1) 
“Changing Thinking”, which involved thought identification/recording and cognitive restructuring, and 2) 
“Changing Doing”, which primarily involved increased involvement in pleasant activities. The program 
was delivered by two facilitators in single-gender groups of 3 to 10 participants (M=6.3). Facilitators 
were trained research assistants in the efficacy trial and high school staff in the effectiveness trial.  
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CB bibliotherapy 
 
Participants in CB bibliotherapy were given copies of Feeling Good[30] and were encouraged to 
use it as a self-help resource. 
 
Brochure control 
 
Participants in the brochure control condition were given a brochure (“Let’s Talk About 
Depression”)[31] that described major depression and recommended treatment. This condition was 
equivalent to usual care. Participants in this condition and the others were permitted to seek any type of 
psychiatric care during the study period.  
 
Measures  
 
Depressive symptoms. Depressive symptoms were assessed using 16 items adapted from the 
Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS).[32] 
Assessments were conducted by blinded trained research assistants at pretest, posttest, and at 6-, 12-, and 
24-month follow-ups. Participants indicated the peak severity of each symptom over the past 12 months 
at pretest or since the last interview in follow-up assessments. Items were averaged to form a continuous 
symptom severity measure (α=.78).  
 
Baseline predictors. Baseline predictors were measured using questionnaires. Negative cognitive 
style was measured using 12 items from the Adolescent Cognitive Style Questionnaire (α=.93).[33] 
Substance use was measured using a 10-item scale asking participants to report the frequency of alcohol 
and drug intake in the past 6-month (α=.77).[34] Motivation to reduce depression was measured using 
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four items developed for this project (e.g., “I am prepared to give this intervention my best shot because I 
really want to overcome my problems with depression”; α=.88). Intervention expectancy was measured 
using 3 items respectively asking participants to rate how much they thought each of the three conditions 
(group to learn skills, self-help book, short pamphlet) would help someone prevent depression (1=not 
very prepared; 5=very prepared). We recoded a single variable reflecting scores for the condition 
participants were assigned to.   
  
Statistical analyses 
 
We conducted Group-Based Trajectory Modeling (also known as Latent Class Growth 
Analysis)[11; 17] in Mplus 6.21.[35] We estimated trajectories with four growth factors (intercept, linear 
growth, quadratic growth, cubic growth) and no within-class variation around these parameters. We 
derived solutions from 1 to 5 classes (models did not converge beyond 5 classes). We used a large 
number of start values (5000, with 100 optimizations) to avoid solutions at local maxima. We considered 
multiple criteria to select the best model.[36] First, we examined information criteria to compare the 
relative fit of trajectory solutions. Second, we considered likelihood ratio tests, which indicate whether a 
solution with k classes offers a significant improvement in fit over a solution with k-1 class(es). Third, we 
took into account the substantive value of each model by evaluating how solutions compared with 
theoretical accounts and previous findings. We also tested Growth Mixture Models[37], which allow for 
within-class variation (or random effects) around growth parameters, in preliminary analyses. However, 
we discarded this approach because these models did not converge adequately.  
After selecting the best-fitting trajectory model, we saved information on most likely class 
membership for all participants and conducted analyses of associations in a separate step. Although 
information is lost by fixing class membership, we chose this strategy to prevent predictors from 
modifying the trajectory solution and because we experienced convergence problems in model-based 
multivariate models using the Mplus R3STEP option. We examined the association between condition 
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and most likely trajectory class membership using a chi-square test, and the association between baseline 
predictors and class membership using multinomial regressions. Individual predictors were considered 
simultaneously in the three conditions adjusting for trial (efficacy vs. effectiveness). We took missing 
data into account using Full Information Maximum Likelihood estimation. 
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Results 
 
Preliminary analyses  
 
We examined differences in study variables between the two trials (Appendix A). The efficacy 
trial included more males and participants with higher baseline symptoms and poorer functioning than the 
effectiveness trial. This probably occurred because of the relaxed symptom requirements in the 
effectiveness trial.[26] We also tested whether the equivalence of baseline depressive symptoms between 
conditions was preserved in the combined efficacy/effectiveness sample. One way ANOVA models 
indicated no difference between conditions on baseline symptoms (F(2, 627)=.48, p=.62). Finally, we 
examined attrition. Rates of missingness were 4% at posttest, and 11% at 6-month, 11% at 12-month, and 
16% at 24-month follow-up. The number of missed assessments was associated with higher baseline 
depressive symptoms (B=.16, p<.05), but was not related to conditions or baseline predictors.  
 
Identification of trajectories 
 
We first derived trajectories separately for each condition to determine whether qualitatively 
distinct solutions existed in intervention and control groups. We found similar solutions in terms of 
number and shape of trajectories (Appendix B) and thus proceeded to identify trajectories in the full 
sample. Table 1 presents information criteria and likelihood ratio tests for various trajectory solutions. Fit 
improved with the number of trajectories, but improvements became more modest in models with more 
than 4 classes. Likelihood ratio tests favored a 4-class solution, except for the bootstrapped likelihood 
ratio test which failed to discriminate solutions. Substantive checking also favored a 4-class solution, 
which we selected.  
Trajectories are displayed in Figure 1. The largest trajectory (58%) was labeled Low-Declining 
and included participants with moderate initial symptoms that decreased from baseline to 6-month follow-
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up and remained relatively stable to 2-year follow-up. The second largest trajectory (26%) was labeled 
High-Declining and included participants with elevated baseline symptoms that decreased steadily from 
baseline to 1-year follow-up and stabilized to 2-year follow-up. The third trajectory (10%) was labeled 
High-Persistent and included participants with elevated initial symptoms that remained elevated through 
2-year follow-up. This trajectory had an inverted U-shaped course with initial increase in symptoms from 
pretest to 6-month follow-up, followed by decline to (elevated) baseline levels. The least prevalent 
trajectory (6%) was labeled Resurging and included participants with elevated baseline symptoms that 
declined from baseline to 6-month follow-up, before dramatically increasing from 6-month follow-up to 
1-year follow-up. Symptoms then declined but remained elevated to 2-year follow-up.    
A chi-square test indicated an overall difference in the prevalence of trajectory membership 
between the two trials (χ²(df=3)=73.7, p<.001). Post hoc comparisons indicated that efficacy trial 
participants were significantly more likely to be members of High-Declining (36% vs. 18%) and High-
Persistent (18% vs. 4%) trajectories, and less likely to be members of the Low-Declining trajectory (42% 
vs. 71%) than effectiveness trial participants.  
 
Association between condition and trajectory class  
 
We next examined the association between condition and trajectory class (Table 2). Chi-square 
test indicated an overall difference in the prevalence of trajectory membership between conditions 
(χ²(df=6)=12.9, p=.04). Post hoc (within-row) comparisons indicated that participants in brochure control 
were significantly more likely to be classified in the High-Persistent trajectory compared to participants in 
CB group (14% vs. 7%) and bibliotherapy (14% vs. 8%). In addition, CB group was associated with 
significantly higher membership in the Low-Declining trajectory compared to brochure controls (64% vs. 
54%). The three conditions did not significantly differ in membership in the High-Declining or Resurging 
classes. 
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Baseline predictors of trajectory class 
 
Table 3 presents associations between baseline predictors and trajectory classes. We used 
multinomial regressions to examine multivariate models with binary and continuous predictors, entering 
trial as a covariate. The presentation of results differs from previous chi-square analyses because 
multinomial regression involves comparisons to specific references classes. We show all pairwise 
comparisons between trajectories using three reference classes (1) Low-Declining versus all other classes 
(compares low versus high initial depression trajectories); (2) High-Declining versus High-Persistent and 
Resurging (compares positive versus negative courses among the highly depressed at baseline); and (3) 
Resurging versus High-Declining (compares the two negative trajectories with negative course). 
Three predictors were associated with significant differences between classes: gender, negative 
cognitive style, and motivation to reduce depressive symptoms. Male gender was associated with 
increased odds of membership in the High-Persistent trajectory relative to the Resurging and Low-
Declining trajectories, as well as the High-Declining trajectory at a trend-level (p=.07). Negative 
cognitive style was higher in High-Declining and High-Persistent trajectories than Resurging and Low-
Declining trajectories. Finally, motivation to reduce depression was higher in High-Declining, High-
Persistent, and Resurging trajectories than the Low-Declining trajectory.  
 
Secondary analyses 
 
We conducted a model-based test of moderation by examining whether the association between 
baseline predictors and trajectory class significantly differed in the three conditions. We used the Model 
Test option in Mplus to obtain Wald tests comparing models with multinomial regression parameters 
constrained to be equal in two specific conditions and models with free regression parameters in the same 
two conditions. This test was repeated for all predictors and all pairwise comparisons between conditions. 
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These analyses revealed no moderation effect, suggesting that baseline predictors had similar associations 
with trajectories in the three conditions.  
We also examined whether other treatments sought by participants affected study findings. These 
analyses were only conducted in the effectiveness trial, since information in the efficacy trial did not 
demarcate adjunctive treatment during or after the intervention phase. Results showed no difference 
between trajectory classes in rates of adjunctive treatment for emotional or behavioral problems during 
the intervention phase, but higher rates of adjunctive treatment during the follow-up phase (posttest to 2 
years) in the High-Persistent and Resurging classes compared to the High-Declining and Low-Declining 
classes (Appendix C).  Rates of antidepressant usage did not differ between trajectories during or after the 
study. These analyses suggest that adjunctive treatment was unlikely to have confounded the association 
between trajectories and CB interventions, but may have resulted from the prolonged experience of 
symptoms in High-Persistent and Resurging trajectories.  
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Discussion 
 
To our knowledge, this study is the first to use group-based trajectory modeling as a clinical 
research tool in adolescent depression prevention research. Using data from two large RCTs,[25; 26] we 
identified four trajectories of symptoms in participants who were and were not exposed to indicated CB 
preventive interventions. Two large trajectories, Low-Declining and High-Declining, had positive 
symptom course. These trajectories were characterized by symptom decline in the first six months 
followed by stabilization and were primarily distinguished on the basis of baseline symptom severity. 
These positive trajectories comprised the majority of participants in CB group and bibliotherapy, but also 
in the brochure control condition with no active intervention. This finding is consistent with research 
indicating high rates of spontaneous remission or placebo response in clinical research on adolescent 
depression.[38] Second, we identified two negative course trajectories. The High-Persistent trajectory was 
characterized by elevated symptoms from pretest to 2-year follow-up with an inverted U-shaped course 
(i.e., increase followed by decline to baseline levels). The Resurging trajectory was characterized by 
strong early reduction followed by a dramatic increase in symptoms.  
Our second objective was to determine how CB interventions related to trajectories. Interestingly, 
exposure to CB interventions did not appear to modify the nature of trajectories because we found 
qualitatively similar solutions in all conditions when investigated separately. However, CB interventions 
modified trajectory membership. Participants in both CB conditions had reduced rates of membership in 
the High-Persistent trajectory compared to brochure control participants, a finding that is consistent with a 
prophylactic effect. In addition, CB group (but not bibliotherapy) participants had an increased rate of 
membership in the Low-Declining class relative to brochure control participants. This finding is more 
challenging to interpret because the Low-Declining class had a positive course, which may have been 
influenced by CB group, but also lower pre-existing symptoms, which would not. It is therefore 
impossible to conclude that this difference represents a CB group effect. No difference in trajectory class 
membership was found between CB group and bibliotherapy. 
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Our third objective was to examine baseline predictors of trajectories. Results from these analyses 
were complex, but may be summed up in three conclusions. First, gender was the most informative 
prognostic factor in its capacity to distinguish the poorest symptom course, High-Persistent, from other 
trajectories. Males had increased odds of being in the High-Persistent trajectory relative to the Low-
Declining and Resurging trajectories, as well as the High-Declining trajectory at a trend-level. A subset of 
males thus had a tendency to experience a chronic form of depression, which may help to explain why 
previous studies have shown poorer effects of CB interventions on males than females.[5; 7; 39] Second, 
motivation to reduce depression was primarily a predictor of initial severity. This factor predicted 
membership in trajectories with elevated baseline symptoms relative to the Low-Declining trajectory, but 
did not distinguish subsequent positive (High-Declining) or negative (High-Persistent, Resurging) course 
among these trajectories. This suggests that baseline motivation did not contribute to intervention 
response or natural improvement, but primarily reflected symptom-induced distress at baseline. Third, 
negative cognitive style was a mixed factor, predicting both positive (High-Declining) and negative 
(High-Persistent) trajectories relative to other positive (Low-Declining) and negative (Resurging) 
trajectories. This predictor appeared to be associated with symptom severity during the early portion of 
the trial, but did not seem to relate to subsequent course. The clinical explanations for this pattern are 
unclear and may depend on complex interactions between factors, such as gender and age. Secondary 
analyses indicated that associations between baseline predictors and trajectory classes did not differ by 
condition, suggesting that these predictors were general predictors of symptom course rather than 
moderators with stronger effects in specific conditions.[40]  
 Several study limitations should be acknowledged. First, we merged samples from two RCTs 
with different inclusion criteria in order to increase sensitivity. Although entering trial as a covariate in 
analyses should have reduced the risk of bias in associational analyses, the use of different samples may 
have influenced the trajectory solution. Second, the prevalence of High-Persistent and Resurging 
trajectories was relatively low, which may have limited statistical sensitivity in analyses involving these 
groups. Third, we included baseline symptoms as part of trajectories, making it difficult to determine the 
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degree to which associations between trajectories and conditions and baseline predictors were related to 
pre-existing symptom levels. Fourth, we conducted separate analyses with fixed class membership, which 
did not take into account uncertainty in trajectory classification. This was however necessary for 
multivariate models to converge. 
This study is the first to describe typical trajectories in an indicated prevention RCT, but 
additional trajectory research will need to replicate our findings. Several questions remain unanswered 
regarding distinctions between trajectories. A key issue for future investigations will be to uncover factors 
associated with the Resurging trajectory. Given the course of symptoms in this class, examination of 
time-varying covariates may prove more informative than a focus on baseline predictors. Another key 
issue will be to examine factors that explain why males were more likely to be in the High-Persistent 
trajectory than females.  
 Our findings extend previous results[25; 26] in several ways and have important clinical 
implications. Most importantly, our findings reveal two distinct poor outcome trajectories that were not 
described before in our prevention trials: a High-Persistent, chronic type trajectory particularly found in 
males and a Resurging, relapse-type trajectory that shows little differentiation from declining trajectories 
at baseline. Although CB interventions were successful at reducing the risk of membership in the High-
Persistent trajectory, both poor outcome trajectories existed in CB group and bibliotherapy conditions 
(roughly comprising 15% of participants). This implies that sustained improvement should not be 
assumed for all participants and that symptoms should be monitored after the intervention. Monitoring 
should be conducted for an extended period (at least 12 months), since participants in the Resurging 
trajectory show strong initial improvement before a worsening of symptoms. Participants in the High-
Persistent and Resurging trajectories may benefit from additional intervention, such as booster sessions or 
more intensive intervention in stepped-care models. Another implication concerns the selection of 
participants for indicated CB prevention. Our results highlight that the large majority of participants (four 
out of five) in the control condition followed a declining trajectory, suggesting that most participants 
selected for indicated prevention may not have needed an intervention. Given the limited resources 
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available to implement prevention in natural settings, improving algorithms to ensure the selection of 
highest risk participants should be a priority of future research.  
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Table 1. Information Criteria and Likelihood Ratio Tests for Trajectory Models with 1 to 5 Classes 
 
    Information Criteria   Likelihood ratio tests 
  
AIC 
 
BIC 
 
ABIC 
 
LMR 
 
VLMR 
 
BLRT 
Number of classes 
  
 
1 3069 
 
3109 
 
3081 
 
– 
 
– 
 
– 
 
2 2507 
 
2569 
 
2524 
 
572.6 *** 
 
555.4 *** 
 
572.6 *** 
 
3 2402 
 
2487 
 
2427 
 
114.2 * 
 
110.7 * 
 
114.2 *** 
 
4 2252 
 
2359 
 
2283 
 
160.4 * 
 
155.6 * 
 
160.4 *** 
 5 2184   2313   2221  78.0  75.7   78.0 *** 
 
AIC = Aikake Information Criterion; BIC = Bayesian Information Criterion; ABIC = Sample-Size Adjusted Bayesian Information Criterion; LMR = Lo-Mendell-Rubin Likelihood 
Ratio Test; VLMR = Vuong-Lo-Mendell-Rubin Likelihood Ratio Test; BLRT = Bootstrapped Likelihood Ratio Test; *** = p < .001; * = p < .05.  
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Table 2. Trajectory Class Membership by Condition  
 
    Prevalence (%) 
  
Condition1 
CB group   CB bibliotherapy   Brochure control 
 
Most likely class 
      
    Low-Declining 64 b   59 a,b   54 a   
    High-Declining 23 a   25 a   28 a   
    High-Persistent 7 b   8 b   14 a   
    Resurging 6 a   8 a   4 a 
1Different subscripts indicate statistically significant differences between conditions in each row 
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Table 3. Baseline Predictors of Trajectory Class Membership 
  
  
Trajectory Class Membership (OR) 
(Ref = Low-Declining) 
 
(Ref = High-Declining) 
 
(Ref = Resurging) 
  
High-Declining 
 
High-Persistent 
 
Resurging 
 
High-Persistent 
 
Resurging 
 
High-Persistent 
Baseline predictors 
           
 
Gender (1=male) 1.3 (0.8–2.0) 
 
2.3 (1.3–4.3)** 0.6 (0.3–1.4) 
 
1.8 (1.0–3.4)  
 
0.5 (0.2–1.0)  
 
3.3 (1.4-10.0)** 
 
Age 1.0 (0.8–1.2) 
 
1.1 (0.8–1.5) 
 
1.4 (1.0–2.0) 
 
1.1 (0.8–1.5) 
 
1.5 (1.0–2.1) 
 
0.8 (0.5-1.1) 
 
Negative cognitive style 1.9 (1.5–2.4)*** 1.7 (1.3–2.4)** 1.0 (0.7–1.4) 
 
0.9 (0.7–1.3) 
 
0.5 (0.4–0.7)*** 1.7 (1.1-2.5) * 
 Substance use 1.5 (0.9–2.4)   1.3 (0.7–2.8)   1.0 (0.5–2.3)  0.9 (0.5–1.8)  0.7 (0.3–1.6)   1.3 (0.5-3.3) 
 
Motivation to reduce Sx 1.6 (1.3–1.9)*** 1.7 (1.1–2.5)* 
 
1.7 (1.1–2.7)* 
 
1.1 (0.7–1.6) 
 
1.1 (0.7–1.8) 
 
1.0 (0.5-1.7) 
 
Intervention expectancy 1.0 (0.8 –1.2) 
 
0.7 (0.5 –1.1) 
 
1.2 (0.8–1.7) 
 
0.7 (0.5–1.1) 
 
1.2 (0.8–1.7) 
 
0.6 (0.5-1.0) 
Sx = Symptoms; *** = p < .001;** = p <.01; * = p < .05  
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Figure Legends 
 
Figure 1. Four Trajectories of Depressive Symptoms Identified in Two Indicated Prevention RCTs 
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Appendix A: Comparison of study variables in efficacy and effectiveness trials 
 
 
    Rate or mean (SD) 
  
Efficacy (Austin) 
 
Effectiveness (Oregon) 
 
Mean or Rate Difference 
Baseline factors    
     Depressive symptoms 1.8 (0.3) 
 
1.4 (0.4) 
 
0.4, p <.001 
 
Gender (1=male) 56.9 
 
32.3 
 
24.6, p<.001 
 
Age 15.5 (1.2) 
 
15.5 (1.2) 
 
0.0, p=.8 
 
Negative cognitive style 3.7 (1.2) 
 
3.5 (1.1) 
 
0.3, p=.005 
 
Substance use 0.5 (0.6) 
 
0.3 (0.6) 
 
0.2, p<.01 
 
Motivation to reduce Sx 3.3 (0.9) 
 
3.0 (1.1) 
 
0.3, p<.001 
 
Intervention expectancy 3.2 (1.1) 
 
3.0 (1.3) 
 
0.2, p=.2 
 
 
 
Appendix B: Separate 4-class trajectory solution by condition 
 
B1. CB Group Trajectories 
 
B2. CB Bibliotherapy Trajectories 
B3. Brochure Control Trajectories 
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Appendix C. Adjunctive treatment by trajectory class 
 
    %   
Chi-Square Test 
  
High-Declining   High-Persistent   Low-Declining   Resurging 
 During the intervention phase 
         
 
Any adjunctive treatment 19 
 
29 
 
20 
 
25 
 
X2 (df=3)=1.08, p=.78 
 
Adjunctive medication 2 
 
0 
 
3 
 
4 
 
X2 (df=3)=0.88, p=.83 
Posttest to 2 year follow-up 
         
 
Any adjunctive treatment 39a 
 
73b 
 
31a 
 
67b 
 
X2 (df=3)=22.42, p<.001 
 Adjunctive medication 6   7   8   15  X2 (df=3)=1.92, p=.59 
1Similar subscripts indicate rates that do not differ statistically for each row 
 
 
 
